| Annual · values | 2025 | 2024 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Gross Margin | 54.65% | 48.64% | 9.59% | -8.79% | -7.42% | 58.01% |
| Operating Margin | 2.91% | -10.02% | -99.11% | -100.57% | -171.83% | -122.61% |
| EBITDA Margin | 13.05% | 7.58% | -55.90% | -55.94% | -131.23% | -89.07% |
| Net Margin | 0.46% | -25.65% | -776.18% | -283.42% | -1231.61% | -122.42% |
| Current Ratio | — | — | — | — | — | — |
| Quick Ratio | — | — | — | — | — | — |
| Debt / Equity | 0.13 | 0.08 | 0.36 | 0.18 | 0.18 | 0.09 |
| ROE | 0.26% | -11.52% | -259.37% | -34.11% | -155.86% | -6.85% |
| ROA | 0.19% | -8.27% | -158.43% | -26.69% | -119.05% | -5.47% |
| Asset Turnover | 0.40 | 0.32 | 0.20 | 0.09 | 0.10 | 0.04 |
| Book Value / Share | 11.10 | 13.92 | 212.11 | 829.25 | 1498.20 | 45223.45 |
Aurora Cannabis Inc. is a Canadian cannabis producer specializing in the cultivation, processing, and sale of medical and adult-use cannabis products. Headquartered in Edmonton, Alberta, the company operates through two main segments: Cannabis and Plant Propagation, providing both finished cannabis goods and starter materials for commercial growers. Aurora Cannabis offers dried flower, pre-rolls, oils, vapes, edibles, and derivative products, addressing a range of consumer and patient needs in regulated markets. It markets its products under multiple brands and participates in both domestic and international medical cannabis channels, supported by export agreements and partnerships. In addition, its plant propagation business supplies agricultural and horticultural sectors with high-quality starter plants. Positioned within the healthcare and specialty drug manufacturing industry, Aurora Cannabis plays a notable role in the evolving legal cannabis market, linking pharmaceutical-style production standards with consumer and medical demand across Canada and select global regions.